Intracellular Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Intracellular Stock Summary

Intracellular competes with Alkermes Plc, Ironwood Pharmaceuticals, Pacira BioSciences,, Collegium Pharmaceutical, and Neurocrine Biosciences. Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. Intra-Cellular Therapies, Inc. was founded in 2002 and is headquartered in New York, New York. Intra-Cellular Ther operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 512 people.

Intracellular Key Financial Ratios

Intracellular Key Balance Sheet Accounts

Intracellular Key Income Statement Accounts

Intracellular Key Cash Accounts

Intracellular Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Intracellular's current stock value. Our valuation model uses many indicators to compare Intracellular value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Intracellular competition to find correlations between indicators driving Intracellular's intrinsic value. More Info.Intracellular Th is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . As of now, Intracellular's Return On Equity is increasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Intracellular's earnings, one of the primary drivers of an investment's value.

Intracellular Th Systematic Risk

Today, most investors in Intracellular Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Intracellular's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Intracellular growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Intracellular help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Intracellular Th. We use our internally-developed statistical techniques to arrive at the intrinsic value of Intracellular Th based on widely used predictive technical indicators. In general, we focus on analyzing Intracellular Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Intracellular's daily price indicators and compare them against related drivers.

When running Intracellular's price analysis, check to measure Intracellular's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intracellular is operating at the current time. Most of Intracellular's value examination focuses on studying past and present price action to predict the probability of Intracellular's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intracellular's price. Additionally, you may evaluate how the addition of Intracellular to your portfolios can decrease your overall portfolio volatility.